BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30776365)

  • 1. Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial.
    Paonessa JR; Shah RD; Pickens CI; Lizza BD; Donnelly HK; Malczynski M; Qi C; Wunderink RG
    Chest; 2019 May; 155(5):999-1007. PubMed ID: 30776365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients with Suspected MRSA Pneumonia.
    Baby N; Faust AC; Smith T; Sheperd LA; Knoll L; Goodman EL
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Puzniak LA; Morrow LE; Huang DB; Barreto JN
    Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
    Wunderink RG; Niederman MS; Kollef MH; Shorr AF; Kunkel MJ; Baruch A; McGee WT; Reisman A; Chastre J
    Clin Infect Dis; 2012 Mar; 54(5):621-9. PubMed ID: 22247123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
    Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
    Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin.
    Equils O; da Costa C; Wible M; Lipsky BA
    BMC Infect Dis; 2016 Sep; 16(1):476. PubMed ID: 27600290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
    Chastre J; Blasi F; Masterton RG; Rello J; Torres A; Welte T
    Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():19-36. PubMed ID: 24580739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.
    Niederman MS; Chastre J; Solem CT; Wan Y; Gao X; Myers DE; Haider S; Li JZ; Stephens JM
    Clin Ther; 2014 Sep; 36(9):1233-1243.e1. PubMed ID: 25066668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia.
    Chavanet P
    Med Mal Infect; 2013 Dec; 43(11-12):451-5. PubMed ID: 24238896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Linezolid and Vancomycin for Methicillin-Resistant Staphylococcus aureus Pneumonia: Institutional Implications.
    Tong MC; Wisniewski CS; Wolf B; Bosso JA
    Pharmacotherapy; 2016 Jul; 36(7):731-9. PubMed ID: 27208687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.
    Wunderink RG; Mendelson MH; Somero MS; Fabian TC; May AK; Bhattacharyya H; Leeper KV; Solomkin JS
    Chest; 2008 Dec; 134(6):1200-1207. PubMed ID: 18719064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic de-escalation in pneumonia with pharmacist education and ordering of methicillin-resistant
    Doan K; Smoke S
    Eur J Hosp Pharm; 2024 Jun; 31(4):327-331. PubMed ID: 36754620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs.
    Martinez-Olondris P; Rigol M; Soy D; Guerrero L; Agusti C; Quera MA; Li Bassi G; Esperatti M; Luque N; Liapikou M; Filella X; Marco F; de la Bellacasa JP; Torres A
    Crit Care Med; 2012 Jan; 40(1):162-8. PubMed ID: 21926613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
    Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; Pichardo C; Ibáñez-Martínez J; Pachón J
    J Antimicrob Chemother; 2012 Aug; 67(8):1961-7. PubMed ID: 22532466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period.
    Yayan J; Ghebremedhin B; Rasche K
    PLoS One; 2015; 10(9):e0138895. PubMed ID: 26398276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis.
    Liu P; Capitano B; Stein A; El-Solh AA
    BMC Nephrol; 2017 May; 18(1):168. PubMed ID: 28532398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
    Wunderink RG; Rello J; Cammarata SK; Croos-Dabrera RV; Kollef MH
    Chest; 2003 Nov; 124(5):1789-97. PubMed ID: 14605050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
    Caffrey AR; Morrill HJ; Puzniak LA; Laplante KL
    Pharmacotherapy; 2014 May; 34(5):473-80. PubMed ID: 24420846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Patel DA; Shorr AF; Chastre J; Niederman M; Simor A; Stephens JM; Charbonneau C; Gao X; Nathwani D
    Crit Care; 2014 Jul; 18(4):R157. PubMed ID: 25053453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly.
    Takada H; Hifumi T; Nishimoto N; Kanemura T; Yoshioka H; Okada I; Kiriu N; Inoue J; Koido Y; Kato H
    Am J Emerg Med; 2017 Feb; 35(2):245-248. PubMed ID: 27832976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.